Anticoagulation in patients with impaired renal function and with haemodialysis: anticoagulant effects, efficacy, safety, therapeutic options = Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse
Patients with impaired renal function are exposed to an increased risk for bleeding complications depending on the amount of the anticoagulant eliminated by the kidneys. The elimination of unfractionated heparins, vitamin K antagonists and argatroban is only minimally influenced by a reduced renal f...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2015
|
| In: |
Hämostaseologie
Year: 2015, Jahrgang: 35, Heft: 1, Pages: 77-83 |
| ISSN: | 2567-5761 |
| DOI: | 10.5482/HAMO-14-08-0036 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.5482/HAMO-14-08-0036 Verlag, Volltext: https://haemo-schattauer-de.ezproxy.medma.uni-heidelberg.de/inhalt/archiv/issue/2177/manuscript/23706.html 
|
| Verfasserangaben: | J. Harenberg, V.A.-T. Hentschel, S. Du, S. Zolfaghari, R. Krämer, C. Weiss, B.K. Krämer, M. Wehling |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 156475829X | ||
| 003 | DE-627 | ||
| 005 | 20230427142100.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171025s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5482/HAMO-14-08-0036 |2 doi | |
| 035 | |a (DE-627)156475829X | ||
| 035 | |a (DE-576)494758295 | ||
| 035 | |a (DE-599)BSZ494758295 | ||
| 035 | |a (OCoLC)1340981060 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Harenberg, Job |d 1950- |e VerfasserIn |0 (DE-588)108825507 |0 (DE-627)655891498 |0 (DE-576)339563745 |4 aut | |
| 245 | 1 | 0 | |a Anticoagulation in patients with impaired renal function and with haemodialysis |b anticoagulant effects, efficacy, safety, therapeutic options = Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse |c J. Harenberg, V.A.-T. Hentschel, S. Du, S. Zolfaghari, R. Krämer, C. Weiss, B.K. Krämer, M. Wehling |
| 246 | 3 | 1 | |a Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse |
| 264 | 1 | |c 2015 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.10.2017 | ||
| 520 | |a Patients with impaired renal function are exposed to an increased risk for bleeding complications depending on the amount of the anticoagulant eliminated by the kidneys. The elimination of unfractionated heparins, vitamin K antagonists and argatroban is only minimally influenced by a reduced renal function. Low-molecular weight heparins, fondaparinux, danaparoid, hirudins and non-vitamin K antagonist oral anticoagulants (NOAC) cause a variably increased bleeding risk in renal impairment. Dose reductions are recommended for all of these anticoagulants in renal impairment, some are even contraindicated at certain levels of renal impairment. Their benefit over the conventional anticoagulants is preserved if renal dosing is employed. For end-stage renal disease patients specific treatment regimens are required. | ||
| 700 | 1 | |a Krämer, Roland |e VerfasserIn |0 (DE-588)1020469730 |0 (DE-627)691227861 |0 (DE-576)360500331 |4 aut | |
| 700 | 1 | |a Weiß, Christel |d 1958- |e VerfasserIn |0 (DE-588)123287707 |0 (DE-627)082463417 |0 (DE-576)168356104 |4 aut | |
| 700 | 1 | |a Krämer, Bernhard |d 1957- |e VerfasserIn |0 (DE-588)14017589X |0 (DE-627)70358927X |0 (DE-576)314926852 |4 aut | |
| 700 | 1 | |a Wehling, Martin |d 1957- |e VerfasserIn |0 (DE-588)129939331 |0 (DE-627)484463152 |0 (DE-576)297912577 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hämostaseologie |d Stuttgart : Thieme, 1981 |g 35(2015), 1, Seite 77-83 |h Online-Ressource |w (DE-627)324742185 |w (DE-600)2030152-2 |w (DE-576)098546333 |x 2567-5761 |7 nnas |a Anticoagulation in patients with impaired renal function and with haemodialysis anticoagulant effects, efficacy, safety, therapeutic options = Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse |
| 773 | 1 | 8 | |g volume:35 |g year:2015 |g number:1 |g pages:77-83 |g extent:7 |a Anticoagulation in patients with impaired renal function and with haemodialysis anticoagulant effects, efficacy, safety, therapeutic options = Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5482/HAMO-14-08-0036 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://haemo-schattauer-de.ezproxy.medma.uni-heidelberg.de/inhalt/archiv/issue/2177/manuscript/23706.html |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20171025 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1020469730 |a Krämer, Roland |m 1020469730:Krämer, Roland |d 120000 |d 120200 |e 120000PK1020469730 |e 120200PK1020469730 |k 0/120000/ |k 1/120000/120200/ |p 5 | ||
| 998 | |g 129939331 |a Wehling, Martin |m 129939331:Wehling, Martin |d 60000 |d 65400 |e 60000PW129939331 |e 65400PW129939331 |k 0/60000/ |k 1/60000/65400/ |p 8 |y j | ||
| 998 | |g 14017589X |a Krämer, Bernhard |m 14017589X:Krämer, Bernhard |d 60000 |d 61400 |e 60000PK14017589X |e 61400PK14017589X |k 0/60000/ |k 1/60000/61400/ |p 7 | ||
| 998 | |g 123287707 |a Weiß, Christel |m 123287707:Weiß, Christel |d 60000 |d 60200 |d 60250 |e 60000PW123287707 |e 60200PW123287707 |e 60250PW123287707 |k 0/60000/ |k 1/60000/60200/ |k 2/60000/60200/60250/ |p 6 | ||
| 998 | |g 108825507 |a Harenberg, Job |m 108825507:Harenberg, Job |d 60000 |d 65400 |e 60000PH108825507 |e 65400PH108825507 |k 0/60000/ |k 1/60000/65400/ |p 1 |x j | ||
| 999 | |a KXP-PPN156475829X |e 2986029108 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Harenberg, Job","role":"aut","given":"Job","family":"Harenberg"},{"family":"Krämer","role":"aut","given":"Roland","display":"Krämer, Roland"},{"display":"Weiß, Christel","role":"aut","given":"Christel","family":"Weiß"},{"role":"aut","given":"Bernhard","family":"Krämer","display":"Krämer, Bernhard"},{"display":"Wehling, Martin","family":"Wehling","given":"Martin","role":"aut"}],"relHost":[{"id":{"zdb":["2030152-2"],"doi":["10.1055/s-00034925"],"issn":["2567-5761"],"eki":["324742185"]},"part":{"pages":"77-83","issue":"1","text":"35(2015), 1, Seite 77-83","extent":"7","year":"2015","volume":"35"},"corporate":[{"display":"Gesellschaft für Thrombose- und Hämostaseforschung","role":"isb"}],"pubHistory":["1.1981,1(März) -"],"language":["ger"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 10.02.2020"],"title":[{"title_sort":"Hämostaseologie","title":"Hämostaseologie","subtitle":"Organ der Gesellschaft für Thrombose- und Hämostaseforschung e.V. (GTH) = Progress in haemostasis"}],"origin":[{"dateIssuedKey":"1981","publisherPlace":"Stuttgart ; Stuttgart","dateIssuedDisp":"1981-","publisher":"Thieme ; Schattauer"}],"titleTranslated":[{"translated":"Progress in haemostasis"}],"disp":"Anticoagulation in patients with impaired renal function and with haemodialysis anticoagulant effects, efficacy, safety, therapeutic options = Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und HämodialyseHämostaseologie","physDesc":[{"extent":"Online-Ressource"}],"recId":"324742185"}],"origin":[{"dateIssuedDisp":"2015","dateIssuedKey":"2015"}],"title":[{"subtitle":"anticoagulant effects, efficacy, safety, therapeutic options = Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse","title_sort":"Anticoagulation in patients with impaired renal function and with haemodialysis","title":"Anticoagulation in patients with impaired renal function and with haemodialysis"}],"note":["Gesehen am 25.10.2017"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"156475829X","physDesc":[{"extent":"7 S."}],"titleTranslated":[{"translated":"Antikoagulation bei Patienten mit eingeschränkter Nierenfunktion und Hämodialyse"}],"name":{"displayForm":["J. Harenberg, V.A.-T. Hentschel, S. Du, S. Zolfaghari, R. Krämer, C. Weiss, B.K. Krämer, M. Wehling"]},"id":{"doi":["10.5482/HAMO-14-08-0036"],"eki":["156475829X"]}} | ||
| SRT | |a HARENBERGJANTICOAGUL2015 | ||